Correction to: Nature Medicine https://doi.org/10.1038/s41591-022-02011-x, published online 3 October 2022.
In the version of this article initially published, the ClinicalTrials.gov registration number, NCT03117998, was missing from the Abstract. It has now been inserted in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pettus, J., Boeder, S.C., Christiansen, M.P. et al. Publisher Correction: Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial. Nat Med 29, 2959 (2023). https://doi.org/10.1038/s41591-023-02301-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-023-02301-y
